Latest stories on CYDY
CytoDyn Presents Updated Leronlimab Data in Metastatic Colorectal Cancer at ESMO Congress 2026
StockTitan58 · neutralproduct/pr
CytoDyn Inc. (CYDY) Discusses Latest Scientific, Clinical, Operational, and Financial Progress and Upcoming Priorities Transcript
Seeking Alpha56 · neutralproduct/pr
CytoDyn Appoints New CEO to Drive Clinical Growth
TipRanks58 · neutralgeneral
CytoDyn appoints Robert Hoffman as CEO
Seeking Alpha58 · neutralgeneral
CytoDyn Inc. (CYDY) files 8-K
SEC 8-K50 · neutralgeneral
CytoDyn Appoints Robert E. Hoffman as Chief Executive Officer
Business Insider58 · neutralgeneral
CytoDyn to Host Investor Webcast
Business Insider52 · neutralproduct/pr
CytoDyn to Host Investor Webcast
GlobeNewswire50 · neutralgeneral
CytoDyn to Present Updated Data from Phase 2 CLOVER Clinical Study at ESMO Congress 2026
StockTitan58 · neutralproduct/pr
CytoDyn Inc. to Present at the Life Sciences Investor Forum on September 17th
Business Insider56 · neutralgeneral
CytoDyn Inc. to Present at the Life Sciences Investor Forum on September 17th
GlobeNewswire56 · neutralgeneral
CytoDyn Closes $16.5 Million Financing to Fund Continued Development of Leronlimab
StockTitan24 · bearishgeneral
CytoDyn Closes $16.5 Million Financing to Fund Continued Development of Leronlimab
GlobeNewswire24 · bearishgeneral
Natera (NTRA), CytoDyn Announce Strategic Collaboration for ctDNA-Guided mCRC Clinical Trials
Yahoo Finance63 · neutralproduct/pr